FDMT - Latest News
4D Molecular Therapeutics, Inc. (FDMT), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $637.2M. Beta to the broader market is 2.69.
The article list below shows the most recent FDMT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent FDMT Headlines
4DMT Announces New Employment Inducement Grants
globenewswire.com - Aug 14, 2026
EMERYVILLE, Calif. , Aug.
4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates
zacks.com - Aug 13, 2026
4D Molecular Therapeutics, Inc. (FDMT) came out with a quarterly loss of $1.
4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
globenewswire.com - Aug 13, 2026
Completed enrollment for 4D-150 4FRONT-2 wet AMD Phase 3; topline data expected in H2 2027 4D-150 4FRONT-1 Phase 3 topline data expected in Q2 2027 P
10 Stock Picks to Celebrate 45 Years of Schaeffer's
schaeffersresearch.com - Jul 29, 2026
Subscribers to Chart of the Week received this commentary on Sunday, July 26.
4D Molecular: 'Buy' Wet-AMD Study Readouts 2027 And DME Expansion Opportunity
seekingalpha.com - Jul 20, 2026
4D Molecular Therapeutics, Inc. maintains a Buy rating, driven by advancing 4D-150 gene therapy for Wet-AMD and DME into late-stage pivotal trials.
How News Affects FDMT Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track FDMT's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked FDMT news questions
- What is the latest FDMT news headline?
- The most recent FDMT headline (Aug 14, 2026) is "4DMT Announces New Employment Inducement Grants". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the FDMT news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What FDMT news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual FDMT options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.